Chief of Head and Neck Surgery, Director of Rob Ebert and Greg Stubblefield Head and Neck Tumor Center at Siteman, Associate Professor
Washington University School of Medicine
St. Louis, MO, United States
Dr. Sid Puram is Chief of Head and Neck Surgery at Washington University in St. Louis, Director of the Rob Ebert and Greg Stubblefield Head and Neck Tumor Center at Siteman, and Associate Professor of Otolaryngology and Genetics. Dr. Puram graduated from MIT, followed by an MD-PhD at Harvard Medical School. He went on to residency at Harvard/Massachusetts Eye and Ear with an in-folded postdoctoral fellowship with Drs. Bradley Bernstein and Aviv Regev at the MIT Broad Institute/Massachusetts General. Thereafter, he completed a surgical oncology/microvascular free flap fellowship at the James Cancer Center/Ohio State University. Currently, Dr. Puram maintains a clinical practice focused on head and neck oncologic surgery, including transoral robotic surgery, open skull base approaches, and microvascular reconstruction. His multiple R01-funded group has been a leader in genetic, transcriptional, and epigenetic heterogeneity in head and neck cancer and its relationship to cancer phenotypes including metastasis and treatment response, with pioneering work in single cell sequencing. He has published over 160 peer-reviewed articles, including studies in Nature, Cell, and Nature Genetics, and delivered over 40 invited national and international lectures. He is Co-Chair of the NCI Clinical Proteomic Tumor Analysis Consortium Thyroid Working Group, Co-Chair of the NRG Oncology Head and Neck Translational Committee, Chair of the Microvascular Committee for the American Academy of Otolaryngology-Head and Neck Surgery, and an active member of the NCI Recurrent/Metastatic Task Force and NRG Head and Neck Core Committee
Swallowing Outcomes of HPV+ OPSCC Survivors by POA(C)RT Dose in the MINT and E3311 Cohorts
Saturday, September 28, 2024
9:30 AM – 9:36 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Saturday, September 28, 2024
1:00 PM – 2:00 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Swallowing Outcomes of HPV+ OPSCC Survivors by POA(C)RT Dose in the MINT and E3311 Cohorts
Saturday, September 28, 2024
2:36 PM – 2:42 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
HPV+ Oropharyngeal Squamous Cell Carcinoma: A Surgical Approach to Management
Sunday, September 29, 2024
9:30 AM – 10:30 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
How to Approach Margins in Head and Neck Cancer: A Practitioner's Guide
Sunday, September 29, 2024
1:00 PM – 2:00 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Long-Term Outcomes of HPV+ Squamous Cell Carcinoma of Unknown Primary Treated With Transoral Surgery
Sunday, September 29, 2024
1:12 PM – 1:18 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Sunday, September 29, 2024
1:24 PM – 1:30 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Older Cancer Patients: To Operate or Not to Operate, Part 2
Monday, September 30, 2024
9:30 AM – 10:30 AM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Monday, September 30, 2024
4:00 PM – 5:00 PM EDT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.